Opin vísindi

Fletta eftir höfundi "Nurmohamed, Michael"

Fletta eftir höfundi "Nurmohamed, Michael"

Röðun: Raða: Niðurstöður:

  • Icon
    Active conventional treatment and three different biological treatments in early rheumatoid arthritis : Phase IV investigator initiated, randomised, observer blinded clinical trial 
    Hetland, Merete Lund; Haavardsholm, Espen A.; Rudin, Anna; Nordström, Dan; Nurmohamed, Michael; Gudbjornsson, Bjorn; Lampa, Jon; Hørslev-Petersen, Kim; Uhlig, Till; Grondal, Gerdur; Østergaard, Mikkel; Heiberg, Marte S.; Twisk, Jos; Lend, Kristina; Krabbe, Simon; Hyldstrup, Lise Hejl; Lindqvist, Joakim; Hultgård Ekwall, Anna Karin; Grøn, Kathrine Lederballe; Kapetanovic, Meliha; Faustini, Francesca; Tuompo, Riitta; Lorenzen, Tove; Cagnotto, Giovanni; Baecklund, Eva; Hendricks, Oliver; Vedder, Daisy; Sokka-Isler, Tuulikki; Husmark, Tomas; Ljoså, Maud Kristine Aga; Brodin, Eli; Ellingsen, Torkell; Söderbergh, Annika; Rizk, Milad; Olsson, Åsa Reckner; Larsson, Per; Uhrenholt, Line; Just, Søren Andreas; Stevens, David John; Laurberg, Trine Bay; Bakland, Gunnstein; Olsen, Inge C.; Van Vollenhoven, Ronald (2020-12-02)
    AbstractObjective To evaluate and compare benefits and harms of three biological treatments with different modes of action versus active conventional treatment in patients with early rheumatoid arthritis. Design Investigator initiated, randomised, open ...
  • Icon
    Methotrexate safety and efficacy in combination therapies in patients with early rheumatoid arthritis : a post-hoc analysis of a randomized controlled trial (NORD-STAR) 
    Lend, Kristina; Koopman, Frieda A; Lampa, Jon; Jansen, Gerrit; L, Merete Hetland; Uhlig, Till; Nordström, Dan; Nurmohamed, Michael; Guðbjörnsson, Björn; Rudin, Anna; Østergaard, Mikkel; Heiberg, Marte S; Sokka-Isler, Tuulikki; Hørslev-Petersen, Kim; Haavardsholm, Espen A; Gröndal, Gerður María; Twisk, Jos W R; van Vollenhoven, Ronald (2023-10-17)
    OBJECTIVE: To investigate methotrexate safety and influence of dose on efficacy outcomes in combination with three different biological treatments and with active conventional treatment (ACT) in early rheumatoid arthritis (RA). METHODS: This post-hoc ...
  • Icon
    Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis 
    Liu, Jianyang; Idborg, Helena; Korotkova, Marina; Lend, Kristina; van Vollenhoven, Ronald; Lampa, Jon; Rudin, Anna; Nordström, Dan; Guðbjörnsson, Björn; Gröndal, Gerður María; Uhlig, Till; Hørslev-Petersen, Kim; Lund Hetland, Merete; Østergaard, Mikkel; Nurmohamed, Michael; Jakobsson, Per-Johan (2024-03-05)
    BACKGROUND: Disease-modifying antirheumatic drugs (DMARDs) are widely used for treating rheumatoid arthritis (RA). However, there are no established biomarkers to predict a patient's response to these therapies. Prostanoids, encompassing prostaglandins, ...